Drug Shortage Report for ATROPINE INJECTION BP
Report ID | 210686 |
Drug Identification Number | 02432188 |
Brand name | ATROPINE INJECTION BP |
Common or Proper name | ATROPINE INJECTION BP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ATROPINE SULFATE |
Strength(s) | 0.4MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1mL |
ATC code | A03BA |
ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-01-01 |
Actual start date | |
Estimated end date | 2024-04-01 |
Actual end date | 2024-04-15 |
Shortage status | Resolved |
Updated date | 2024-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-04-16 | French | Compare |
v4 | 2024-04-16 | English | Compare |
v3 | 2024-01-02 | English | Compare |
v2 | 2023-11-17 | French | Compare |
v1 | 2023-11-17 | English | Compare |
Showing 1 to 5 of 5